LIANYOTCPharmaceutical PreparationsFiscal year ends December 31
LianBio
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q on Nov 13, 2023
$0.06+0.01 (+15.10%)
Close on Oct 19, 2026
- Market cap
- $6.29M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0048 (−7.56%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2023
Valuation
- Market cap
- $6.29M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.03
- Dividend yield
- –
- Free cash flow yield
- -1335.15%
Fundamentals
- Net income
- -$87.98M
- EPS, diluted
- -$0.81
- Free cash flow
- -$83.99M
- Book value per share
- $1.89
- Diluted shares
- 107M
Four years at a glance
Fiscal years 2019 to 2022 and trailing twelve months, USD
Operating income
-$106.56M
Net income
-$87.98M
EPS, diluted
-$0.81
Free cash flow
-$83.99M
Reported periodTrailing twelve months